Daimaru Enawin Co., Ltd.
Daimaru Enawin Co., Ltd. Second Quarter (Interim) Financial Summary [Japanese GAAP] (Consolidated)
For the interim period of the fiscal year ending March 31, 2027, consolidated net sales were 17,998 million yen (Year-over-Year +18.4%), operating income was 575 million yen, ordinary income was 651 million yen, and net income attributable to owners of parent was 412 million yen (Year-over-Year +92.2%). By segment, the Living segment recorded significant revenue and profit growth; the Medical & Industrial Gas segment posted higher revenue but a narrower profit increase. Overall profit increased. Financial position is sound with net assets of 16,278 million yen, equity ratio of 70.8%, increases in cash and deposits, and decreases in certain assets. There is no change to the full-year earnings guidance. Dividend forecast remains unchanged with a year-end dividend of 15 yen for the fiscal year ending March 2027.
Key Figures
- Net Sales: 17,698 million yen (Year-over-Year +18.4%)
- Operating Income: 575 million yen (Year-over-Year +61.7%)
- Net Income Attributable to Owners of Parent: 412 million yen (Year-over-Year +92.2%)
AI要約
Overview of Results
Net sales for the interim period increased year-over-year, supported by higher LP gas selling prices in the Living segment and growth in home medical equipment rentals, and overall segments showed steady trends. Operating income recorded a substantial increase, exceeding the rise in selling, general and administrative expenses, and ordinary income and interim net income also achieved significant increases. The high profitability contribution from the Living segment particularly drove overall results. Financial position remains solid, with an equity ratio of approximately 70.8% and net assets of approximately 16,278 million yen. There is no change to the previously announced full-year forecast.
Outlook and Dividends
The earnings forecast for the fiscal year remains unchanged as previously announced. Regarding dividends, irrespective of first and second quarter-end results, the full-year dividend forecast for the fiscal year ending March 31, 2027 remains unchanged, and the date for announcing the year-end dividend has been determined. By segment, steady demand for home medical care and medical gas is expected to sustain profitability improvements in the Medical & Industrial Gas segment; however, attention should be paid to external factors such as fluctuations in LP gas prices and energy market trends.
Daimaru Enawin Co., Ltd.
Company overview · Stock price · Financial data · All IR
